MicroPort Scientific Corporation (SEHK:853) announced the spin-off of an unknown stake in MicroPort (Shanghai) MedBot Co., Ltd. on December 11, 2020. Under the spin-off, shareholders will get 1 share for every integral multiple of 1,100 Shares held by Qualifying Shareholders on October 4, 2021, the Record Date. Pursuant to the terms of the transaction, MicroPort Scientific Corporation will separately list the shares of MicroPort MedBot (Shanghai) Co., Ltd., on a recognized stock exchange.

As of February 4, 2021, the offering raised approximately HKD 2.5 billion. The spin-off and listing are subject to, among others, market conditions and approvals from the relevant regulatory authorities. Richard Spooner of Maples & Calder Asia, Sidley Austin LLP and Commerce & Finance Law Offices acted as legal advisors to MicroPort (Shanghai) MedBot.

Simpson Thacher & Bartlett and Jingtian & Gongcheng acted as legal advisors to the underwriters.